上周(2025 年7 月7 日-7 月11 日),A 股申万医药生物上涨1.82%,板块整体跑赢沪深300 指数1pct,跑输创业板综指数0.39pct。在申万31 个一级子行业中,医药板块周涨跌幅排名为第16 位。恒生医疗保健指数上涨0.05%,板块整体跑输恒生指数0.88pct。在恒生12 个一级子行业中,医疗保健行业周涨跌幅排名为第9 位。核心观点重磅交易落地,艾伯维引进CD3/BCMA/...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.